Dry mouth

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%

Anticholinergic therapy caused significantly more dry mouth than onabotulinumtoxinA (46% vs 31%, P=0.02), though dry mouth was not a major cause of drug withdrawal.

Effect: adverse; 46% vs 31%